Under these conditions, tumor cells often use acetate as alternative carbon source for acetyl-CoA production by AceCS2 and although tumor cells display low acetate concentration, this metabolite may be advantageous (Comerford et al., 2014). The gene discussed is ACSS1; the disease is neoplasm.